Filter
5899
Filtered Results: 5899
Text search:
drug
treatment
Featured
Recommendations
506
New Publications
1516
Language
Document type
No document type
3672
Studies & Reports
824
Guidelines
701
Manuals
234
Strategic & Response Plan
155
Fact sheets
115
Training Material
78
Situation Updates
58
Infographics
24
Resource Platforms
15
Brochures
14
Online Courses
7
App
1
Videos
1
Countries / Regions
India
368
Kenya
175
Global
165
South Africa
146
Western and Central Europe
131
Ethiopia
131
Uganda
123
Nigeria
112
Nepal
103
Tanzania
99
Liberia
93
Sierra Leone
89
Zambia
88
Malawi
87
Africa
83
Latin America and the Carribbean
78
Myanmar / Burma
74
Ghana
72
Bangladesh
72
Eastern Europe
71
Ukraine
65
Rwanda
61
Namibia
54
Philippines
49
Zimbabwe
47
Russia
45
Asia
42
Indonesia
41
Lesotho
38
Cambodia
37
South–East Asia Region
34
Mozambique
31
Botswana
30
Senegal
28
Congo, Democratic Republic of
27
Syria
26
Germany
25
Brazil
25
Eswatini/ Swaziland
23
Colombia
21
Burkina Faso
20
East and Southern Africa
20
South Sudan
20
Venezuela
17
West and Central Africa
17
USA
16
Middle East and North Africa
16
Cameroon
14
Eastern Europe and Central Asia
14
Haiti
13
Albania
12
Pakistan
12
Tajikistan
11
Guinea
11
Georgia
11
Thailand
10
Argentina
10
China
9
Afghanistan
9
Sudan
9
Peru
8
Vietnam
8
Yemen
7
North Macedonia
6
Benin
6
Armenia
6
Bolivia
6
Moldova
6
Angola
6
Mexico
5
El Salvador
5
Western Pacific Region
5
Lebanon
5
Papua New Guinea
5
Iraq
5
Somalia
5
Laos
4
Estonia
4
Guinea-Bissau
4
Jordan
4
Paraguay
4
Jamaica
4
United Kingdom
4
Southern Africa
4
Sri Lanka
4
Central African Republic
4
Libya
4
Bhutan
4
Ecuador
4
Timor Leste/ East Timor
3
Turkey
3
Iran
3
Fiji
3
Kyrgyzstan
3
Uzbekistan
3
Morocco
3
North America
3
Spain
3
Palestine
3
Mali
3
Switzerland
2
Serbia
2
Kazakhstan
2
Chile
2
Canada
2
Mongolia
2
Hungary
2
Saudi Arabia
2
Portugal
2
Belarus
2
Romania
2
Poland
2
Madagascar
2
North Korea
1
Australia
1
Gambia
1
Singapore
1
Malaysia
1
Qatar
1
Bulgaria
1
Italy
1
Lithuania
1
Ireland
1
Gabon
1
Uruguay
1
Turkmenistan
1
Denmark
1
Belgium
1
France
1
Maldives
1
Mauritius
1
Tunisia
1
Norway
1
Côte d’Ivoire / Ivory Coast
1
Egypt
1
Greece
1
Honduras
1
Chad
1
Solomon Islands
1
Authors & Publishers
Publication Years
Category
Countries
2234
Clinical Guidelines
556
Public Health
272
Women & Child Health
219
Key Resources
93
Capacity Building
92
Pharmacy & Technologies
59
Annual Report MEDBOX
1
Toolboxes
HIV
736
TB
677
Mental Health
634
AMR
282
COVID-19
240
NTDs
210
Pharmacy
179
NCDs
133
Caregiver
111
Ebola
93
Rapid Response
90
Refugee
83
Conflict
63
Planetary Health
62
Disability
60
Global Health Education
48
Health Financing Toolbox
29
Polio
23
Specific Hazards
19
Cholera
19
Natural Hazards
18
Zika
16
Social Ethics
15
Health Financing
1
What countries need: Investments needed for 2010 targets
Unpreparedness of health professionals to address non-communicable diseases (NCD) at peripheral health facilities is a critical health system challenge in Mozambique. To address this weakness and decentralize NCD care, training of the primary care workforce is needed. We describe our experience in t...
More than 40% of the world population is 24 years old or younger, the vast majority of whom live in low- and lower middle–income countries. Globally, a quarter of disability-adjusted life years (DALYs) for mental disorders and substance abuse is borne by this age group and about 75% of mental diso...
As the Group of Eight (G8) world leaders meet in Saint Petersburg, Russia for this year’s G8 Summit, it is important to take stock of international efforts to finance the response to the global HIV/AIDS epidemic. Financing a sufficient and sustained response to the epidemic has emerged as one of t...
This paper explores the angles and opportunities of digital health, with a look
at digital innovation and its potential to support patients with circulatory diseases.
In reviewing developments in the field, current applications as well as gaps, the paper aims to support policymakers in leveraging ...
The World Heart Federation (WHF) commenced a Roadmap initiative in 2015 to reduce the global burden of cardiovascular disease and resultant burgeoning of healthcare costs. Roadmaps provide a blueprint for implementation of priority solutions for the principal cardiovascular diseases leading to death...
Many low- and middle-income countries (LMICs) are undergoing an epidemiological transition. With an improvement in socioeconomic conditions and an aging population, cardiovascular diseases (CVDs), like cardiac arrhythmias, are expected to increase in these countries. However, there are limited studi...
Non-communicable diseases (NCDs) are of increasing concern for society and national governments, as well as globally due to their high mortality rate. The main risk factors of NCDs can be classified into the categories of self-management, genetic factors, environmental factors, factors of medical co...
The evolving epidemic of type 2 diabetes mellitus has challenged health-care professionals. It stands among the leading causes of mortality in the present world. It warrants new and versatile approaches to improve mortality and the associated huge quality-adjusted life years lost to it once diagnose...
Diabetes is a significant public health issue that affects approximately one in 10 adults globally, with type 2 diabetes accounting for 90–95% of cases. This chronic condition causes considerable morbidity and mortality and is growing in impact, with cases projected to rise from 537 million in 202...
Since 2016, the Pan American Health Organization (PAHO) has been promoting the implementation of the HEARTS Initiative in the Americas as a regional adaptation of the World Health Organization's Global HEARTS Initiative. During this time, 33 countries in the Region of the Americas have committed to ...
Long Acting Muscarinic Antagonists (LAMA) such as tiotropium and glycopyrronium are used in the management of COPD1. They have been shown to improve lung function, quality of life and exercise tolerance. They have also been associated with reduced COPD-related exacerbations, associated hospitalisati...
Diabetes mellitus is a major cause of morbidity and mortality in Scotland and worldwide, with an increasing prevalence. In 2009 there were around 228,000 people registered as having diabetes in Scotland, an increase of 3.6% from the preceding year. This increase relates, in part, to the increasing a...
The Public Health Burden of Commercial Tobacco Use
The burden of disease and death from commercial tobacco* use in the United States is
overwhelmingly caused by cigarettes and other combustible tobacco products.
Diabetes mellitus is one of the most common noncommunicable diseases worldwide. In the Eastern Mediterranean Region there has been a rapid increase in the incidence of diabetes mellitus and it is now the fourth leading cause of death. The increasing prevalence of diabetes mellitus, the emergence of ...
Diabetes is a significant public health issue that affects approximately one in 10 adults globally, with type 2 diabetes accounting for 90–95% of cases. This chronic condition causes considerable morbidity and mortality and is growing in impact, with cases projected to rise from 537 million in 202...
This global status report on prevention and control of NCDs (2014), is framed around the nine voluntary global targets. The report provides data on the current situation, identifying bottlenecks as well as opportunities and priority actions for attaining the targets. The 2010 baseline estimates on N...
This report is one of the first major products of the newly established Precision Public Health Metrics unit of the UCN cluster of the WHO Regional Office for Africa. The report presents national trends in communicable and non-communicable disease burden and control in the WHO African region. It tra...
This module covers common Non-Communicable Diseases such as Hypertension, Diabetes and three common cancers (Cervical,
Breast and Oral cancer). The focus of this module is on building the knowledge and skills of the Multi-Purpose Workers (MPW) in
undertaking Population Based Screening, identifi ca...
This study identifies barriers and provides recommendations to improve asthma care in children across sub-Saharan Africa, where qualitative data is lacking despite high rates.
